US STOCKS-MannKind, Magnum Hunter among premarket actives

NEW YORK, Sept 25 (Reuters) - MannKind Corp shares
were among the most actively traded in premarket on Thursday,
after the company said it had closed a licensing agreement with
Sanofi for the development and commercialization of
its inhaled insulin product.

MannKind said it will receive a $150 million upfront payment
within 10 days of the closing.

Shares were trading up 3.6 percent to $6.30 before the
opening bell on volume of over 60,000 shares, putting it in the
top-10 most actively traded issues on the Nasdaq.

Magnum Hunter shares were surging 12.8 percent to
$6.16 before the opening bell after the company announced its
throughput volumes on its Eureka Hunter gas gathering pipeline
system.

The gain would mark the biggest percentage jump for the
stock since April 2013 should it hold throughout the session.
Volume of 128,000 represents about 3.6 percent of its 50-day
moving average.

U.S. stock index futures were little changed on Thursday,
after the S&P 500 notched its biggest gain in a month, ahead of
data on the labor market and durable goods.

The S&P 500 snapped a three-day losing skid on
Wednesday in a broad advance, led by healthcare and biotech
stocks, with gains in the housing sector also providing support
after surprisingly strong data on the sector.
Continuación...